Poster 1714

A Phase 1/2 Study of INCB000928 as Monotherapy or Combined With Ruxolitinib in Patients With Anemia due to Myelofibrosis

Sanjay Mohan, MD, MSCI

Presented at the ASH Annual Meeting 2022 New Orleans, Louisiana | December 10-13, 2022